MIRA PHARMACEUTICALS INC (MIRA)
US60458C1045 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.64M | 8.53M | 7.05M | 2.15M | 67.63K | |||
| Research and Development | 2.83M | 1.57M | 2.35M | 684.45K | 14.65K | |||
| Selling, General, and Administrative Expenses | 5.81M | 6.95M | 4.70M | 1.47M | 52.98K | |||
| Operating Income | -8.64M | -8.53M | -7.05M | -2.15M | -67.63K | |||
| Interest Income/Expense | -2.60M | -3.46M | -10.25K | -24.37K | -360.00 | |||
| Income Before Taxes | -11.24M | -11.98M | -7.06M | -2.18M | -67.99K | |||
| Net Income | -11.24M | -11.98M | -7.06M | -2.18M | -67.99K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.73 | -0.81 | -0.48 | -0.15 | -0.00 | |||
| Statistics | ||||||||
All data in USD